Introduction: A relatively high proportion of patients who undergo partial or radical nephrectomy for enhancing renal mass actually have oncocytoma, a benign renal tumor. Several parameters have been shown to be typical for oncocytoma, but only a small number of patients present with these parameters. The aim of our study was to report the clinical, operative and postoperative characteristics of patients who underwent nephron-sparing surgery in our center with a histopathological diagnosis of oncocytoma compared to patients with malignant renal tumor. Patients and Methods: Sixty-three out of 530 patients who underwent nephron-sparing surgery for enhancing renal mass were diagnosed with oncocytoma. Clinical and radiological features and operational data of these patients were compared with patients who had malignant renal tumors. Results: Mean age of patients with histologically proven non-malignant oncocytoma was significantly higher than that in patients with malignant renal cell carcinoma (66.7 vs. 61.4 years). All other analyzed variables showed no significant difference between the 2 groups. Conclusions: No reliable clinical, operative or radiological parameters can differentiate preoperatively between oncocytoma and malignant renal neoplasms.

Keywords:
Oncocytoma, Renal cell carcinoma, Nephron-sparing surgery
1.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-1334.
2.
Dechet CB, Bostwick DG, Blute ML, Bryant SC, Zincke H: Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 1999;162:40-42.
3.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H: Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003;170:2217-2220.
4.
Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P: Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 2006;176:2391-2395.
5.
Meyer C, Hansen J, Becker A, Schmid M, Pradel L, Strini K, et al: The adoption of nephron-sparing surgery in Europe - a trend analysis in two referral centers from Austria and Germany. Urol Int 2015, DOI: 10.1159/000442215.
6.
Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A: Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009;64:517-522.
7.
Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis CJ Jr: Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 1993;186:693-696.
8.
Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, et al: Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24:835-842.
9.
Bahouth Z, Halachmi S, Getzler I, Caspin O, Moskovitz B, Nativ O: Functional and oncological outcomes of open nephron-sparing surgery for complex renal masses. Urol Oncol 2015;33:427.e11-e16.
10.
Wein AJ, Kavoussi LR, Campbell MF: Campbell-Walsh Urology, ed 10. Philadelphia, Elsevier Saunders, 2012.
11.
Kawaguchi S, Fernandes KA, Finelli A, Robinette M, Fleshner N, Jewett MA: Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance. J Urol 2011;186:1218-1222.
12.
Kurup AN, Thompson RH, Leibovich BC, Harmsen WS, Sebo TJ, Callstrom MR, et al: Renal oncocytoma growth rates before intervention. BJU Int 2012;110:1444-1448.
13.
Choi JH, Kim JW, Lee JY, Han WK, Rha KH, Choi YD, et al: Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas. Korean J Urol 2015;56:695-702.
14.
Sasaguri K, Takahashi N, Gomez-Cardona D, Leng S, Schmit GD, Carter RE, et al: Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. Am J Roentgenol 2015;205:999-1007.
15.
Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, et al: Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology 2013;81:1265-1272.
16.
Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS: MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Am J Roentgenol 2010;195:W421-W427.
17.
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al: EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67:913-924.
18.
Lebret T, Poulain JE, Molinie V, Herve JM, Denoux Y, Guth A, et al: Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol 2007;178:1184-1188.
19.
Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C: Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 2004;171:1802-1805.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.